By evaluating the amplification status of 71 genes in mainly advanced gastric cancers from a Caucasian population of patients and by its correlation with patient survival, two members of the cell cycle regulation system, CCND1 and CDKN1B, were identified as potential candidates for assessment of prognosis. This evidence concerns the gene CDKN1B and gastric cancer.